Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-11 |
mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-11 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-10 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-09 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.2 | 7e-09 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-09 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-08 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-08 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-08 |